We are live on ! Find out more
CCM

Carderock Capital Management Portfolio holdings

AUM $456M
1-Year Est. Return 31.89%
This Fund
S&P 500
This Quarter Est. Return
+7.2%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$203M
AUM Growth
+$8.24M
Cap. Flow
-$3.46M
Cap. Flow %
-1.7%
Top 10 Hldgs %
27.99%
Holding
91
New
1
Increased
52
Reduced
19
Closed
4

Top Buys

Rank Stock Value
1
HON icon
Honeywell
HON
+$249K
2
SBUX icon
Starbucks
SBUX
+$226K
3
CDK
CDK Global, Inc.
CDK
+$204K
4
BDX icon
Becton Dickinson
BDX
+$149K
5
KMI icon
Kinder Morgan
KMI
+$146K

Top Sells

Rank Stock Value
1
MRO
Marathon Oil Corporation
MRO
+$1.12M
2
KEX icon
Kirby Corp
KEX
+$1.08M
3
SLB icon
SLB Ltd
SLB
+$873K
4
CLB icon
Core Laboratories
CLB
+$863K
5
NOV icon
NOV
NOV
+$765K

Sector Composition

Rank Sector Weight
1 Healthcare 24.41%
2 Technology 23.38%
3 Industrials 15.37%
4 Consumer Discretionary 6.17%
5 Financials 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
51
Starbucks
SBUX
$121B
$1.29M 0.64%
31,470
+5,788
+23% +$226K
TROW icon
52
T. Rowe Price
TROW
$24.5B
$1.28M 0.63%
14,898
+1
+0% +$82
BCE icon
53
BCE
BCE
$20.6B
$1.17M 0.58%
25,542
-33
-0.1% -$1.48K
QCOM icon
54
Qualcomm
QCOM
$165B
$1.12M 0.55%
15,104
-131
-0.9% -$9.59K
DCI icon
55
Donaldson
DCI
$11.3B
$1.06M 0.52%
27,391
-150
-0.5% -$5.96K
SLB icon
56
SLB Ltd
SLB
$74.1B
$1.06M 0.52%
12,360
-9,490
-43% -$873K
JNJ icon
57
Johnson & Johnson
JNJ
$621B
$991K 0.49%
9,476
BMY icon
58
Bristol-Myers Squibb
BMY
$130B
$865K 0.43%
14,650
BMO icon
59
Bank of Montreal
BMO
$127B
$808K 0.4%
11,417
BCR
60
DELISTED
CR Bard Inc.
BCR
$679K 0.33%
4,075
+300
+8% +$48.5K
SJM icon
61
J.M. Smucker
SJM
$12.7B
$669K 0.33%
6,625
-1,475
-18% -$149K
IHG icon
62
InterContinental Hotels
IHG
$23.9B
$646K 0.32%
12,231
-1,744
-12% -$89.1K
BDX icon
63
Becton Dickinson
BDX
$47B
$645K 0.32%
4,749
+1,168
+33% +$149K
ENB icon
64
Enbridge
ENB
$113B
$636K 0.31%
12,376
+19
+0.2% +$895
HON icon
65
Honeywell
HON
$78.6B
$595K 0.29%
6,622
+2,894
+78% +$249K
D icon
66
Dominion Energy
D
$60B
$580K 0.29%
7,539
+241
+3% +$17.4K
KMI icon
67
Kinder Morgan
KMI
$69.3B
$580K 0.29%
13,711
+3,711
+37% +$146K
CTXS
68
DELISTED
Citrix Systems Inc
CTXS
$520K 0.26%
10,242
MRK icon
69
Merck
MRK
$317B
$500K 0.25%
9,224
ITW icon
70
Illinois Tool Works
ITW
$85.5B
$492K 0.24%
5,192
+229
+5% +$20.9K
XOM icon
71
ExxonMobil
XOM
$628B
$437K 0.22%
4,729
+669
+16% +$62.4K
CVS icon
72
CVS Health
CVS
$126B
$425K 0.21%
4,410
+110
+3% +$9.69K
MTD icon
73
Mettler-Toledo International
MTD
$28.5B
$416K 0.2%
1,375
KEX icon
74
Kirby Corp
KEX
$7.01B
$387K 0.19%
4,795
-10,944
-70% -$1.08M
WFC icon
75
Wells Fargo
WFC
$270B
$360K 0.18%
6,560
+159
+2% +$8.42K

Similar funds

Carderock Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Carderock Capital Management held 91 positions worth $203M, up 4.2% from $195M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Carderock Capital Management's Q4 2014 filing shows 1 new, 52 increased, 19 reduced and 4 closed positions. Its largest new stake was CDK Global, Inc.: 5,771 shares worth $235K. The largest sale was Marathon Oil Corporation, an estimated $1.12M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Carderock Capital Management's largest Q4 2014 buy was CDK Global, Inc.: 5,771 shares worth $235K.
  • Carderock Capital Management added most to Honeywell in Q4 2014, an estimated $249K increase.
  • Carderock Capital Management's biggest Q4 2014 reduction was Kirby Corp, cutting an estimated $1.08M.
  • Carderock Capital Management fully exited Marathon Oil Corporation in Q4 2014, selling an estimated $1.12M.
  • Carderock Capital Management's ten largest holdings make up 28% of its $203M portfolio in Q4 2014.
  • Carderock Capital Management opened 1 new position and closed 4 in Q4 2014.
  • Carderock Capital Management's portfolio value rose 4.2% quarter-over-quarter to $203M.

Based on Carderock Capital Management's 13F filing for Q4 2014, filed 11 Feb 2015.